PatientGroupDirection.com is the brain child of community pharmacist and digital
entrepreneur Mike Bereza. For the past 2 years he has worked as the manager of a small
independent called Douglas Pharmacy based in Islington, London. Mike has been offering
patients access to travel medicines and specific POMs via PGDs and the revenues gained
have been exceptional.
PatientgroupDirection can now offer a fully CQC authorised service to pharmacies
nationwide.
There are a handful of providers offering a similar service however, they offer an
incomplete selection of relatively expensive PGDs. Some providers offer influenza
immunisations but not malaria prophylaxis, others offer erectile dysfunction but not
vaccinations. PatientGroupDirection.com can offer a complete centralised package of all
PGDs, giving them the greatest variety, better value, exceptional training and support,
guaranteed.
PGDs we offer include:
•Erectile dysfunction: Sildenafil (Viagra), Vardenafil (Levitra), Tadalafil (Cialis) - £50 pa.
•Smoking cessation: Varenicline (Champix) - £50 pa.
•Hair loss: Finasteride (Propecia) - £50 pa.
•Anti malarials: Malarone, Mefloquine (Lariam), Doxycycline - £100 pa.
•Shingles: Zoster vaccine to protect 50yo+ patients from shingles - £150 pa.
•Flu jab: Influenza vaccination with free Hepatitis B PGD - £250 (NPA £360 pa!)
•Travel clinic: Typhoid, Rabies, MMR, DTP, Meningitis, Japanese Encephalitis, Cholera, Hepatitis
A + B, Combined Vaccines - have a look at our case study and price list!
•Bespoke PGDs: We can create and authorise any suitable PGD just contact us.
If clients are interested in more than one PGD, we can offer group discounts for
subscriptions with multiple PGDs.
Our pharmacist created training resources fulfil all guidance as set out by the
TRAVAX/HPA and have been created as to be as straight forward as possible. There is
minimal paperwork and most of a pharmacies go live in less than 2 weeks from the initial
subscription.
Please have a look at our site or call us on 020 8150 7199 to find out more about a
significant new opportunity in the UK pharmacy sector.
No comments:
Post a Comment